Session 1 Sunday 7 April 8:30-10:00

Advances in Biomarkers for Assessing Efficacy of Aerosol Therapies

Moderators: Scott Donaldson (University of NC, Chapel Hill) and Paula Anderson (University of Arkansas)

Beyond FEV1: Latest Biomarkers for Adult Airway Disease

Steve Rowe, MD
University of Alabama at Birmingham

Challenges and Limitations for Testing Efficacy of New Aerosol Therapies in Young Children

Stephanie Davis, MD
University of Indiana

Pre-clinical Studies in Sheep using Aerosols to Target Asthma and Chronic Bronchitis

Bill Abraham, PhD
Mount Sinai Medical Center
Miami Beach, FL

Animal Models for Assessing Aerosolized Vaccines

Chad J Roy, PhD
Tulane University
New Orleans, LA